Venetoclax in combination with fludarabine, cytarabine, granulocyte colony stimulating factor, and idarubicin (FLAG-Ida) in patients with acute leukemia of ambiguous lineage and acute lymphoblastic leukemia
Leukemia & Lymphoma | January 16, 2025 | Volume: 66 | Issue: 4 | Pages: 780-784
10.1080/10428194.2024.2443017
| PMID 39817316